These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock. Tunctan B, Korkmaz B, Sari AN, Kacan M, Unsal D, Serin MS, Buharalioglu CK, Sahan-Firat S, Cuez T, Schunck WH, Manthati VL, Falck JR, Malik KU. Nitric Oxide; 2013 Sep 01; 33():18-41. PubMed ID: 23684565 [Abstract] [Full Text] [Related]
3. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells. El-Sehemy A, Chang AC, Azad AK, Gupta N, Xu Z, Steed H, Karsan A, Fu Y. Cell Signal; 2013 Dec 01; 25(12):2780-7. PubMed ID: 24041655 [Abstract] [Full Text] [Related]
4. Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation. Perkins WJ, Kost S, Danielson M. Am J Physiol Lung Cell Mol Physiol; 2009 Apr 01; 296(4):L666-73. PubMed ID: 19181745 [Abstract] [Full Text] [Related]
5. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770. Alexandre EC, Leiria LO, Silva FH, Mendes-Silvério CB, Calmasini FB, Davel AP, Mónica FZ, De Nucci G, Antunes E. J Pharmacol Exp Ther; 2014 Apr 01; 349(1):2-9. PubMed ID: 24421320 [Abstract] [Full Text] [Related]
6. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation. Mujoo K, Sharin VG, Martin E, Choi BK, Sloan C, Nikonoff LE, Kots AY, Murad F. Nitric Oxide; 2010 Jan 01; 22(1):43-50. PubMed ID: 19948239 [Abstract] [Full Text] [Related]
7. Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide. Perkins WJ, Taniguchi M, Warner DO, Chini EN, Jones KA. Am J Physiol Lung Cell Mol Physiol; 2007 Jul 01; 293(1):L84-95. PubMed ID: 17384083 [Abstract] [Full Text] [Related]
8. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells. Kostic TS, Andric SA, Stojilkovic SS. Mol Endocrinol; 2004 Feb 01; 18(2):458-70. PubMed ID: 14630997 [Abstract] [Full Text] [Related]
9. Nitric oxide stimulates interleukin-6 production in skeletal myotubes. Makris AC, Sotzios Y, Zhou Z, Makropoulou M, Papapetropoulos N, Zacharatos P, Pyriochou A, Roussos C, Papapetropoulos A, Vassilakopoulos T. J Interferon Cytokine Res; 2010 May 01; 30(5):321-7. PubMed ID: 20035621 [Abstract] [Full Text] [Related]
10. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice. Teixeira CE, Priviero FB, Webb RC. J Pharmacol Exp Ther; 2007 Sep 01; 322(3):1093-102. PubMed ID: 17596536 [Abstract] [Full Text] [Related]
11. Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP. Ivanova K, Lambers B, van den Wijngaard R, Le Poole IC, Grigorieva O, Gerzer R, Das PK. In Vitro Cell Dev Biol Anim; 2008 Sep 01; 44(8-9):385-95. PubMed ID: 18594937 [Abstract] [Full Text] [Related]
12. Activation of nitric oxide signaling pathway mediates hypotensive effect of Muntingia calabura L. (Tiliaceae) leaf extract. Shih CD, Chen JJ, Lee HH. Am J Chin Med; 2006 Sep 01; 34(5):857-72. PubMed ID: 17080550 [Abstract] [Full Text] [Related]
13. Differential expression of functional guanylyl cyclases in melanocytes: absence of nitric-oxide-sensitive isoform in metastatic cells. Ivanova K, Das PK, van den Wijngaard RM, Lenz W, Klockenbring T, Malcharzyk V, Drummer C, Gerzer R. J Invest Dermatol; 2001 Mar 01; 116(3):409-16. PubMed ID: 11231315 [Abstract] [Full Text] [Related]
14. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway. Bouallegue A, Daou GB, Srivastava AK. Am J Physiol Heart Circ Physiol; 2007 Oct 01; 293(4):H2072-9. PubMed ID: 17644565 [Abstract] [Full Text] [Related]
15. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases. Dupont LL, Glynos C, Bracke KR, Brouckaert P, Brusselle GG. Pulm Pharmacol Ther; 2014 Oct 01; 29(1):1-6. PubMed ID: 25043200 [Abstract] [Full Text] [Related]
16. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase. Newton M, Niewczas I, Clark J, Bellamy TC. Anal Biochem; 2010 Jul 15; 402(2):129-36. PubMed ID: 20371357 [Abstract] [Full Text] [Related]
17. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Feelisch M, Kotsonis P, Siebe J, Clement B, Schmidt HH. Mol Pharmacol; 1999 Aug 15; 56(2):243-53. PubMed ID: 10419542 [Abstract] [Full Text] [Related]
18. Regulation of nitric oxide and soluble guanylyl cyclase. Krumenacker JS, Hanafy KA, Murad F. Brain Res Bull; 2004 Feb 15; 62(6):505-15. PubMed ID: 15036565 [Abstract] [Full Text] [Related]
19. Nitric oxide/soluble guanylyl cyclase signaling mediates depolarization-induced protection of rat mesencephalic dopaminergic neurons from MPP⁺ cytotoxicity. Kurauchi Y, Hisatsune A, Isohama Y, Sawa T, Akaike T, Katsuki H. Neuroscience; 2013 Feb 12; 231():206-15. PubMed ID: 23238575 [Abstract] [Full Text] [Related]
20. Structure and regulation of soluble guanylate cyclase. Derbyshire ER, Marletta MA. Annu Rev Biochem; 2012 Feb 12; 81():533-59. PubMed ID: 22404633 [Abstract] [Full Text] [Related] Page: [Next] [New Search]